Internal medicine journal
-
Internal medicine journal · Mar 2021
Efficacy and tolerability of febuxostat in gout patients on dialysis.
There are no sufficient data available on the use of febuxostat in patients undergoing dialysis. ⋯ Febuxostat is efficacious and well tolerated in gout patients on dialysis. Febuxostat taken at dose of 20-40 mg/day might be appropriate initial dose in patients undergoing dialysis.
-
Internal medicine journal · Mar 2021
Respiratory failure, clinical course and community management of COVID-19 patients in a large Australian cohort.
Coronavirus disease 2019 (COVID-19) has wreaked health and economic damage globally. A thorough understanding of the characteristics of COVID-19 patients in Australia plus the strategies that successfully 'flatten the curve' are vitally important to contain this pandemic. ⋯ A comprehensive COVID-19 management model is needed to successfully manage COVID-19 patients in both outpatient and inpatient settings in order to 'squash the curve'.